Previsioni di mercato della matrice extracellulare per l’America meridionale e centrale fino al 2027 – Impatto del COVID-19 e analisi regionale per applicazione (riparazione e ricostruzione vascolare, riparazione durale, guarigione delle ferite, riparazione cardiaca, riparazione pericardica, riparazione dei tessuti molli); Materia prima (bovina, suina, altra materia prima) e Paese

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 144    |    Report Code: TIPRE00016493    |    Category: Life Sciences

South and Central America Extracellular Matrix Market

Il mercato della matrice extracellulare dell\'America meridionale e centrale è stato valutato a 989,99 migliaia di dollari nel 2019 e si prevede che raggiungerà 11.708,44 migliaia di dollari entro il 2027; si prevede che cresca a un CAGR del 7,1%  dal 2020 al 2027.

 

La crescita del mercato è attribuita alla crescente incidenza di traumi e malattie cardiovascolari e aumento delle procedure di ricostruzione vascolare. Tuttavia, le sfide associate all\'utilizzo della matrice extracellulare decellularizzata, come l\'insufficiente conservazione del sistema vascolare e della composizione della matrice extracellulare, ostacolano la crescita del mercato.

 

L\'incidenza significativamente crescente delle condizioni di trauma ortopedico e delle malattie cardiovascolari, tra gli altri, sono i fattori principali per la crescita del mercato della matrice extracellulare del Sud e Centro America. Come parte del trattamento, la matrice extracellulare offre numerosi vantaggi per il trattamento di diverse lesioni croniche causate da interventi chirurgici, incidenti, malattie croniche e altro. Malattie croniche come il cancro, le malattie cardiache, le malattie muscolo-scheletriche e altre sono le principali cause di morte e disabilità. La consapevolezza dei trattamenti tecnologicamente avanzati e delle procedure minimamente invasive richiede trattamenti efficaci in tempi minori. Pertanto, uno dei vantaggi della matrice extracellulare è soddisfare la domanda dei pazienti.

 

Inoltre, l\'epidemia di COVID-19 sta avendo un impatto negativo i sistemi sanitari sovraccarichi e sottofinanziati del Sud e Centro America. Gli ospedali sono già sovraccarichi a causa del trattamento delle malattie trasmesse da vettori e delle infezioni acquisite in comunità e degli alti tassi di malattie non trasmissibili (NCD). Dall\'inizio del COVID-19, la prevenzione e il trattamento delle malattie non trasmissibili come il diabete e le complicanze ad esso associate sono stati colpiti in modo critico nella regione, secondo l\'Organizzazione Panamericana della Sanità (OPS).

< p> 

Entrate e previsioni del mercato della matrice extracellulare dell\'America del Sud e Centro fino al 2027 (migliaia di dollari)


 

Segmentazione del mercato della matrice extracellulare dell\'America centrale e meridionale

  ;

Per applicazione

  • Riparazione e ricostruzione vascolare
  • < li>Riparazione durale
  • Guarigione delle ferite
  • Riparazione cardiaca
  • Riparazione del pericardio
  • Riparazione dei tessuti molli


Per materia prima

  • Bovino
  • Suino
  • Altre materie prime

 

Profili aziendali           

  • Organogenesis Inc.
  • Integra Life Sciences Corporation
  • Mölnlycke Health Care AB
  • Anika Therapeutics, Inc.
  • ACell Inc.
  • MIROMATRIX MEDICAL Inc
  • Acera Surgical Inc., CorMatrix, Inc.
  • Hollister Incorporated
  • MLM Biologics Inc.
  • Harbor MedTech, Inc.< /li>


South and Central America Extracellular Matrix Strategic Insights

Strategic insights for South and Central America Extracellular Matrix involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-extracellular-matrix-market-strategic-framework.webp
Get more information on this report

South and Central America Extracellular Matrix Report Scope

Report Attribute Details
Market size in 2019 US$ 989.99 thousand
Market Size by 2027 US$ 11,708.44 thousand
Global CAGR (2020 - 2027) 7.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Applicazione
  • riparazione e ricostruzione vascolare
  • riparazione durale
  • guarigione delle ferite
  • riparazione cardiaca
  • riparazione pericardica
  • riparazione dei tessuti molli
By Materia prima
  • bovina
  • suina
  • altre materie prime
Regions and Countries Covered America meridionale e centrale
  • Brasile
  • Argentina
  • resto delAmerica meridionale e centrale
Market leaders and key company profiles
  • Organogenesis Inc.
  • Integra Life Sciences Corporation
  • Mölnlycke Health Care AB
  • Anika Therapeutics, Inc.
  • ACell Inc.
  • MIROMATRIX MEDICAL Inc
  • Acera Surgical Inc., CorMatrix, Inc.
  • Hollister Incorporated
  • MLM Biologics Inc.
  • Harbor MedTech, Inc.
  • Get more information on this report

    South and Central America Extracellular Matrix Regional Insights

    The regional scope of South and Central America Extracellular Matrix refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-extracellular-matrix-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Extracellular Matrix Market

    The List of Companies - South and Central America Extracellular Matrix Market

    1. Organogenesis Inc.
    2. Integra Life Sciences Corporation
    3. Mölnlycke Health Care AB
    4. Anika Therapeutics, Inc.
    5. ACell Inc.
    6. MIROMATRIX MEDICAL Inc
    7. Acera Surgical Inc., CorMatrix, Inc.
    8. Hollister Incorporated
    9. MLM Biologics Inc.
    10. Harbor MedTech, Inc.

     

     

    Frequently Asked Questions
    How big is the South and Central America Extracellular Matrix Market?

    The South and Central America Extracellular Matrix Market is valued at US$ 989.99 thousand in 2019, it is projected to reach US$ 11,708.44 thousand by 2027.

    What is the CAGR for South and Central America Extracellular Matrix Market by (2020 - 2027)?

    As per our report South and Central America Extracellular Matrix Market, the market size is valued at US$ 989.99 thousand in 2019, projecting it to reach US$ 11,708.44 thousand by 2027. This translates to a CAGR of approximately 7.1% during the forecast period.

    What segments are covered in this report?

    The South and Central America Extracellular Matrix Market report typically cover these key segments-

  • Applicazione (riparazione e ricostruzione vascolare, riparazione durale, guarigione delle ferite, riparazione cardiaca, riparazione pericardica, riparazione dei tessuti molli)
  • Materia prima (bovina, suina, altre materie prime)
  • What is the historic period, base year, and forecast period taken for South and Central America Extracellular Matrix Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Extracellular Matrix Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South and Central America Extracellular Matrix Market?

    The South and Central America Extracellular Matrix Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Organogenesis Inc.
  • Integra Life Sciences Corporation
  • Mölnlycke Health Care AB
  • Anika Therapeutics, Inc.
  • ACell Inc.
  • MIROMATRIX MEDICAL Inc
  • Acera Surgical Inc., CorMatrix, Inc.
  • Hollister Incorporated
  • MLM Biologics Inc.
  • Harbor MedTech, Inc.
  • Who should buy this report?

    The South and Central America Extracellular Matrix Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Extracellular Matrix Market value chain can benefit from the information contained in a comprehensive market report.